Register
Question 1
What is the overall purpose of biotherapy in cancer treatment?
Correct Answer:
To enhance the immune response against cancer cells
Explanation:
The overall purpose of biotherapy in cancer treatment is to enhance the immune response against cancer cells. Biotherapy, also known as immunotherapy, involves using the body’s own immune system to fight cancer. This form of treatment can take various approaches, such as monoclonal antibodies, vaccines, immune checkpoint inhibitors, and cytokines, all designed to stimulate or enhance the natural defenses of the immune system. By targeting and bolstering the body’s immune response, biotherapy aims to identify and destroy cancer cells more effectively than conventional treatments. This method can also help the immune system remember cancer cells, potentially offering long-term protection against recurrence. While biotherapy might also contribute to minimizing side effects or providing supportive care, its primary role is focused on activating and strengthening the immune response against tumors. This distinguishes it from other types of cancer treatments, which may directly destroy tumor cells or provide nutritional support.
Question 2
What is a defining feature of cell cycle non-specific drugs?
Correct Answer:
They act on dividing and resting cells
Explanation:
The defining feature of cell cycle non-specific drugs is that they have the ability to act on both dividing and resting cells. This characteristic sets them apart from cell cycle-specific agents, which are effective only during particular phases of the cell cycle, such as the G1, S, or G2 phases. Non-specific drugs can target cancer cells regardless of whether they are actively dividing or in a quiescent state, making them versatile in their application against a variety of tumors. This broad activity is particularly beneficial for treating tumors that may have a mix of actively dividing and resting cells. It provides an opportunity to affect a larger percentage of the tumor population, potentially leading to better treatment outcomes. This property is crucial in oncology, as solid tumors often have regions of cells in various phases of the cell cycle. The other options do not accurately describe the nature of cell cycle non-specific drugs. Their effectiveness is not limited to a specific phase, they can be administered via different routes beyond just intravenous, and hair loss, while a common side effect of many chemotherapy agents, is not a defining characteristic of non-specific drugs.
Question 3
During which phase of the cell cycle do mitotic inhibitors demonstrate their effects?
Correct Answer:
M phase
Explanation:
Mitotic inhibitors are a class of drugs that specifically target the M phase of the cell cycle, which is when mitosis, or cell division, occurs. These inhibitors work by disrupting the process of spindle formation necessary for chromosomal segregation, effectively preventing the cell from completing mitosis. This action exploits the critical period when cells are preparing to divide, thereby halting the progression of the cell cycle and leading to cell death, particularly in rapidly dividing cancer cells. While the other phases, such as G1, G2, and S, involve important preparations for DNA synthesis and cell division, mitotic inhibitors do not exert their primary effects during these phases. Instead, their action is specifically focused on disrupting the actual process of mitosis, emphasizing their unique role in cancer treatment. Understanding the phase in which these drugs operate is crucial for effectively using them in chemotherapy regimens.
Question 4
Why are age-specific dosages important in pediatric chemotherapy?
Correct Answer:
Pediatric physiology varies significantly from adults
Explanation:
Age-specific dosages are crucial in pediatric chemotherapy because the physiology of children differs significantly from that of adults. Pediatric patients are not just smaller versions of adults; their organs, metabolism, and body composition can drastically affect how drugs are absorbed, distributed, metabolized, and excreted. The developmental stages of children introduce variation in drug pharmacokinetics and pharmacodynamics. For instance, younger children may have immature liver and kidney functions, which play key roles in drug metabolism and clearance. Additionally, differences in total body water and fat composition can alter the distribution of medications. These factors highlight the importance of calculating chemotherapy doses based on a child's age, weight, and developmental stage to ensure efficacy while minimizing toxicity. Administering adult dosages without adjustments can lead to under-treatment or excessive side effects in pediatric patients.
Question 5
What is the recommended action if a patient exhibits signs of anaphylaxis during treatment?
Correct Answer:
Administer oxygen and call for emergency help
Explanation:
When a patient exhibits signs of anaphylaxis during treatment, the immediate priority is to ensure the patient's safety and address the life-threatening reaction promptly. Administering oxygen and calling for emergency help is the correct action because anaphylaxis can lead to airway obstruction, difficulty breathing, and a drop in blood pressure, all of which require rapid medical intervention. Administering oxygen helps to improve oxygenation, and calling for emergency help ensures that appropriate medical assistance is on its way, which may include interventions like epinephrine administration and advanced airway management. Taking these actions can be life-saving and should be the first response when signs of anaphylaxis are noted. Continuing treatment or checking the patient's chart for allergies is inappropriate in this situation, as it can delay critical care. Providing a snack is also not relevant and could potentially exacerbate the situation if the patient's airway is compromised or if they are unable to swallow due to swelling.
Question 1
Exam overview

About this Exam

The Oncology Nursing Certification Corporation (ONCC) Chemotherapy Immunotherapy Certificate Course, frequently referred to as the ONS Chemotherapy Biotherapy Certification, is a critical validation of knowledge for Registered Nurses (RNs) who administer and manage the care of patients receiving these complex treatments. This course is specifically designed to provide healthcare professionals with the fundamental knowledge and evidence-based skills necessary to safely deliver antineoplastic agents, including conventional chemotherapy and newer biotherapeutic or immunotherapeutic drugs. By passing the final assessment of this course, nurses demonstrate their commitment to patient safety, treatment excellence, and their specialized expertise in oncology care. 

More details

Additional Information

What the Course Entails and Exam Details

This comprehensive online, self-paced course typically requires approximately 15 hours to complete. It provides a foundational curriculum that goes far beyond simple administration techniques. The course entails a deep dive into several core competencies and theoretical frameworks, essential for any nurse in the oncology field. Key topics covered include a detailed analysis of cell cycle biology and mechanisms of drug action, principles of apoptosis and hematopoiesis, and the specifics of immunology. RNs will master the management of potential side effects, distinguishing between those that are dose-limiting and those that are manageable, with specific focus on chemotherapy-induced nausea and vomiting (CINV), cutaneous reactions, and venous irritation. Practical application is reinforced through training on proper intravenous (IV) access selection, safe handling procedures, and unique drug class considerations, such as antineoplastic antibiotics and plant alkaloids.

 

 

 What to Expect in the Final Exam

The final assessment for the ONCC Chemotherapy Immunotherapy Certificate is not a standalone "final exam" in a physical center, but rather a "post-test" integrated directly into the online course curriculum. After completing all course modules, learners will unlock this mandatory assessment, which consists of multiple-choice questions designed to measure retention of the core topics. To successfully complete the course and receive the ONCC provider card, participants must achieve a passing score of 80% or higher. Understanding the pressure this can bring, the program typically allows learners two attempts to pass the post-test within their active course enrollment period. If both attempts are unsuccessful, the student will need to repurchase the course to try again. The test is non-proctored and is not strictly "timed" in the same way as a full proctored certification exam, allowing you to focus on accuracy rather than speed.

 

 

 

How to Study and Exam Centers

Your primary study resource is the course material itself. As this is a comprehensive certificate program, active engagement with every module, taking detailed notes, and reviewing the rationales provided within the lessons is crucial for success. In addition to the standard coursework, the ONCC highly recommends utilizing their official practice tests to gauge your readiness and become familiar with the question style. One free, non-reusable 50-item practice test is available for each learner, while an additional, randomized 100-item practice test with full rationales can be purchased for more intensive preparation. As noted, you will not need to locate a physical exam center; the entire process—from studying to taking the final post-test—is completed within the ONS/ONCC online learning platform, offering you the flexibility to prepare and test from your own home or workplace.

 

 

 Job Opportunities from the Course

Successfully completing the ONCC Chemotherapy Immunotherapy Certificate Course unlocks direct pathways to specialized nursing roles and demonstrates a competitive edge in the job market. This certificate is often a prerequisite for RNs wishing to practice in oncology settings. It directly qualifies you for and enhances your candidacy for specific career paths such as:

  • Oncology Nurse (RN): A specialized nurse who cares for cancer patients throughout their treatment journey.
  • Chemotherapy Infusion Nurse: A highly skilled RN who focuses specifically on the safe calculation, preparation, and administration of chemotherapy agents in outpatient clinics or hospital units.
  • Infusion RN / IV Therapy Nurse: A nurse whose expertise in venous access and agent administration can be utilized in broader infusion settings.
  • Nurse Educator (Oncology): With clinical experience, this certificate can be the first step towards a career in educating other nurses about safe drug administration.
  • Stepping Stone to Full Certification: This foundational knowledge is also excellent preparation for achieving full, proctored specialty certifications, such as the OCN® (Oncology Certified Nurse), CBCN® (Certified Breast Care Nurse), or CPHON® (Certified Pediatric Hematology Oncology Nurse), which can lead to further leadership and advanced practice roles.
Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions

2026 FFM Agent Broker Certification Practice Exam

0 min

3CX Academy Advanced Certification Practice Exam

0 min

3CX Academy Basic Certification Practice Exam

0 min

3CX Intermediate Certification Practice Exam

0 min

Ultimate Study Guide for the Argus Certification Practice Test

0 min

Arizona Caregiver Certification Practice Exam

0 min